Item Type | Name |
Academic Article
|
Sickle cell trait is not independently associated with susceptibility to end-stage renal disease in African Americans.
|
Academic Article
|
Target organ damage in African American hypertension: role of APOL1.
|
Academic Article
|
Genetic association and gene-gene interaction analyses in African American dialysis patients with nondiabetic nephropathy.
|
Academic Article
|
The new era of APOL1-associated glomerulosclerosis.
|
Academic Article
|
Apolipoprotein L1 gene variants associate with hypertension-attributed nephropathy and the rate of kidney function decline in African Americans.
|
Academic Article
|
Association of trypanolytic ApoL1 variants with kidney disease in African Americans.
|
Academic Article
|
The apolipoprotein L1 (APOL1) gene and nondiabetic nephropathy in African Americans.
|
Academic Article
|
Intensive blood-pressure control in hypertensive chronic kidney disease.
|
Academic Article
|
Effects of race on albuminuria and risk of cardiovascular and kidney disease.
|
Academic Article
|
Differential effects of MYH9 and APOL1 risk variants on FRMD3 Association with Diabetic ESRD in African Americans.
|
Academic Article
|
Apolipoprotein L1 nephropathy risk variants associate with HDL subfraction concentration in African Americans.
|
Academic Article
|
Insights into the genetic architecture of diabetic nephropathy.
|
Academic Article
|
Association of APOL1 variants with mild kidney disease in the first-degree relatives of African American patients with non-diabetic end-stage renal disease.
|
Concept
|
Apolipoprotein A-I
|
Academic Article
|
APOL1 and progression of nondiabetic nephropathy.
|
Academic Article
|
APOL1 and nephropathy progression in populations of African ancestry.
|
Academic Article
|
JC polyoma virus interacts with APOL1 in African Americans with nondiabetic nephropathy.
|
Academic Article
|
APOL1 risk variants, race, and progression of chronic kidney disease.
|
Academic Article
|
APOL1 associations with nephropathy, atherosclerosis, and all-cause mortality in African Americans with type 2 diabetes.
|
Academic Article
|
The impact of APOL1, CAV1, and ABCB1 gene variants on outcomes in kidney transplantation: donor and recipient effects.
|
Academic Article
|
Gene-gene interactions in APOL1-associated nephropathy.
|
Academic Article
|
Analysis of coding variants identified from exome sequencing resources for association with diabetic and non-diabetic nephropathy in African Americans.
|
Academic Article
|
End-stage renal disease in African Americans with lupus nephritis is associated with APOL1.
|
Academic Article
|
Evaluation of candidate nephropathy susceptibility genes in a genome-wide association study of African American diabetic kidney disease.
|
Academic Article
|
Gene-gene and gene-environment interactions in apolipoprotein L1 gene-associated nephropathy.
|
Academic Article
|
Coding variants in nephrin (NPHS1) and susceptibility to nephropathy in African Americans.
|
Academic Article
|
Apolipoprotein L1 gene variants associate with prevalent kidney but not prevalent cardiovascular disease in the Systolic Blood Pressure Intervention Trial.
|
Academic Article
|
Histopathologic findings associated with APOL1 risk variants in chronic kidney disease.
|
Academic Article
|
Localization of APOL1 protein and mRNA in the human kidney: nondiseased tissue, primary cells, and immortalized cell lines.
|
Academic Article
|
Should kidney donors be genotyped for APOL1 risk alleles?
|
Academic Article
|
Lack of Association of the APOL1 G3 Haplotype in African Americans with ESRD.
|
Academic Article
|
Apolipoprotein L1-associated nephropathy and the future of renal diagnostics.
|
Academic Article
|
APOL1 G1 genotype modifies the association between HDLC and kidney function in African Americans.
|
Academic Article
|
APOL1 and kidney disease: new insights leading to novel therapies.
|
Academic Article
|
Biogenesis and cytotoxicity of APOL1 renal risk variant proteins in hepatocytes and hepatoma cells.
|
Academic Article
|
Deceased donor multidrug resistance protein 1 and caveolin 1 gene variants may influence allograft survival in kidney transplantation.
|
Academic Article
|
Re-Sequencing of the APOL1-APOL4 and MYH9 Gene Regions in African Americans Does Not Identify Additional Risks for CKD Progression.
|
Academic Article
|
APOL1 Genotype and Kidney Transplantation Outcomes From Deceased African American Donors.
|
Academic Article
|
Characterization of circulating APOL1 protein complexes in African Americans.
|
Academic Article
|
Deceased-Donor Apolipoprotein L1 Renal-Risk Variants Have Minimal Effects on Liver Transplant Outcomes.
|
Academic Article
|
APOL1 nephropathy risk variants are associated with altered high-density lipoprotein profiles in African Americans.
|
Academic Article
|
APOL1 renal-risk genotypes associate with longer hemodialysis survival in prevalent nondiabetic African American patients with end-stage renal disease.
|
Academic Article
|
APOL1 renal-risk variants associate with reduced cerebral white matter lesion volume and increased gray matter volume.
|
Academic Article
|
APOL1 Renal-Risk Variants Induce Mitochondrial Dysfunction.
|
Academic Article
|
APOL1 Gene Kidney Risk Variants and Cardiovascular Disease: Getting to the Heart of the Matter.
|
Academic Article
|
APOL1 genotype, blood pressure, and survival in African Americans with nondiabetic nephropathy.
|
Grant
|
Genetic Determinants of Renal Transplant Survival from African American Donors
|
Grant
|
An Integrative Genomic Approach to APOL1-Associated Nephropathy.
|
Academic Article
|
The Apolipoprotein L1 Gene and Cardiovascular Disease.
|
Academic Article
|
A null variant in the apolipoprotein L3 gene is associated with non-diabetic nephropathy.
|
Academic Article
|
A tripartite complex of suPAR, APOL1 risk variants and avß3 integrin on podocytes mediates chronic kidney disease.
|
Grant
|
Wake Forest APOLLO Scientific and Data Research Center
|
Academic Article
|
Apolipoprotein L1 Gene Effects on Kidney Transplantation.
|
Academic Article
|
FGF23 Concentration and APOL1 Genotype Are Novel Predictors of Mortality in African Americans With Type 2 Diabetes.
|
Academic Article
|
JC polyoma viruria associates with protection from chronic kidney disease independently from apolipoprotein L1 genotype in African Americans.
|
Academic Article
|
Evaluation of Potential Living Kidney Donors in the APOL1 Era.
|
Academic Article
|
Genome-wide association studies suggest that APOL1-environment interactions more likely trigger kidney disease in African Americans with nondiabetic nephropathy than strong APOL1-second gene interactions.
|
Academic Article
|
The APOL1 Long-Term Kidney Transplantation Outcomes Network-APOLLO.
|
Academic Article
|
Response to Comment on Chan et al. FGF23 Concentration and APOL1 Genotype Are Novel Predictors of Mortality in African Americans With Type 2 Diabetes. Diabetes Care 2018;41:178-186.
|
Academic Article
|
APOL1 Kidney Risk Variants and Cardiovascular Disease: An Individual Participant Data Meta-Analysis.
|
Academic Article
|
Protective association between JC polyoma viruria and kidney disease.
|
Academic Article
|
APOL1 and Mortality in Patients on Dialysis.
|
Academic Article
|
The Impact of APOL1 on Chronic Kidney Disease and Hypertension.
|
Academic Article
|
Nephropathy Progression in African Americans With a Family History of ESKD: Implications for Clinical Trials in APOL1-Associated Nephropathy.
|
Academic Article
|
APOL1-Associated Nephropathy: A Key Contributor to Racial Disparities in CKD.
|
Academic Article
|
Donor APOL1 high-risk genotypes are associated with increased risk and inferior prognosis of de novo collapsing glomerulopathy in renal allografts.
|
Academic Article
|
Mechanisms of Injury in APOL1-associated Kidney Disease.
|
Academic Article
|
Apolipoprotein L1 Testing in African Americans: Involving the Community in Policy Discussions.
|
Academic Article
|
Effect of a Single Apolipoprotein L1 Gene Nephropathy Variant on the Risk of Advanced Lupus Nephritis in Brazilians.
|
Academic Article
|
APOL1 Nephropathy Risk Variant Associations with Diseases beyond the Kidney: APOL1 and Sepsis.
|
Academic Article
|
Practical Considerations for APOL1 Genotyping in the Living Kidney Donor Evaluation.
|